Benefits of Breast Cancer Index

Video Library - Interview with the Innovators
Susan K. Boolbol, MD
Stephen C. Malamud, MD
Dr Stephen C. Malamud and Dr Susan K. Boolbol consider the clinical utility of the Breast Cancer IndexSM (BCI) as a test that separates those patients who are more likely to benefit from those who are unlikely to benefit from extended endocrine therapy.
Related Items
Unclear Diagnoses in Patients with Metastatic Disease
Ralph V. Boccia, MD, FACP
Video Library published on April 14, 2015 in Interview with the Innovators
The bioT3 platform
Ralph V. Boccia, MD, FACP
Video Library published on April 14, 2015 in Interview with the Innovators
Clinical Validation of CancerTYPE ID
Ralph V. Boccia, MD, FACP
Video Library published on April 14, 2015 in Interview with the Innovators
CancerTYPE ID in the Clinic
Ralph V. Boccia, MD, FACP
Video Library published on April 14, 2015 in Interview with the Innovators
CancerTREATMENT NGS+ in the Clinic
Ralph V. Boccia, MD, FACP
Video Library published on April 14, 2015 in Interview with the Innovators
Last modified: March 24, 2015
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • National Association of Specialty Pharmacy
  • Lynx CME